ZOIE HULST: Open Payments
NPI 1831895093 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 59 payments from 12 companies in 2025. Trend: 2023 $200 · 2024 $1,210 · 2025 $1,912
Food & beverage: $1,728Education: $185
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $484 |
| ABBVIE INC. | 24 | $454 |
| Galderma Laboratories, L.P. | 6 | $166 |
| GENZYME CORPORATION | 2 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $164 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| UCB, Inc. | 1 | $118 |
| Amgen Inc. | 3 | $72 |
| Lilly USA, LLC | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $31 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, NEMLUVIO, Bimzelx, OTEZLA, ILUMYA.
Industry payments across FL — which companies pay providers there.
